NASDAQ: CNTG - Centogene N.V.

半年間の収益性: -70.32%
セクタ: Healthcare

プロモーションスケジュール Centogene N.V.


会社について

Centogene N.V., together with its subsidiaries, engages in the research and development of products for human genetics in Europe, the Middle East, North America, Latin America, and the Asia Pacific. It provides data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It operates through two segments: Pharmaceutical and Diagnostics. The company provides target and drug screening, clinical development, market access and expansion, as well as CENTOGENE Biodatabank licenses and insight report services.

さらに詳しく
In addition, it offers various services, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.

IPO date 2019-11-07
ISIN NL0014040206
Industry Health Care Providers & Services
Sector Health Care
Валюта usd
Валюта отчета eur
Сайт https://www.centogene.com
Цена ао 0.2238
1日あたりの価格変動: 0% (0.1211)
週ごとの価格変動: -9.9% (0.1344)
月ごとの料金変更: +34.56% (0.09)
3ヶ月間の価格変動: -39.45% (0.2)
半年間の価格変動: -70.32% (0.408)
年間の価格変動: -89.91% (1.2)
3年間の価格推移: -97.66% (5.17)
5年間の価格推移: -99.07% (13.05)
10年間の価格推移: 0% (0.1211)
年初からの価格変動: +28.15% (0.0945)

過小評価

名前 意味 学年
P/S 0.6114 10
P/BV -1.48 0
P/E 0 0
EV/EBITDA -2.93 0
合計: 5

効率

名前 意味 学年
ROA, % -45.07 0
ROE, % 137.55 10
合計: 3.33

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA -2.2 10
合計: 9.4

成長の衝動

名前 意味 学年
収益性 Revenue, % -2.54 0
収益性 Ebitda, % 142.23 10
収益性 EPS, % -94.96 0
合計: 5.6



スーパーバイザー 役職 支払い 生年
Ms. Kim Stratton CEO & Member of Management Board 932.62k 1962 (63 年)
Mr. Jose Miguel Coego Rios CFO, Legal & IT and Member of Management Board 323.87k 1974 (51 年)
Dr. Peter Bauer M.D. Interim MD, Chief Medical & Genomic Officer and Member of Management Board 186.31k 1970 (55 年)
Dr. Andrin Oswald M.D., Ph.D. Advisor 943.45k 1972 (53 年)
Mr. Ian Rentsch Chief Commercial Officer & GM of Pharma N/A 1976 (49 年)

住所: Germany, Rostock, Am Strande 7 - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.centogene.com